- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Drug Pipelines
- September 2020
- 50 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Drug Pipelines
- June 2018
- 43 Pages
Global
From €3384EUR$3,500USD£2,906GBP
- Report
- July 2023
- 97 Pages
Global
From €3500EUR$3,878USD£3,112GBP
The Tinnitus Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat tinnitus, a condition characterized by a ringing or buzzing sound in the ears. These drugs are typically used to reduce the severity of the symptoms, and may include medications such as anticonvulsants, antidepressants, and anti-anxiety drugs. In some cases, alternative treatments such as acupuncture, hypnosis, and cognitive behavioral therapy may be used in conjunction with drug therapy.
The Tinnitus Drug market is highly competitive, with many companies offering products to treat the condition. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Other companies such as Allergan, Teva Pharmaceuticals, and Mylan also offer products for tinnitus treatment. Show Less Read more
